Clinical significance and biological roles of cyclins in gastric cancer

References

• MurrayCJVosTLozanoRDisability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592197222323245608
   PubMed Web of Science ®Google Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• FerlayJShinHRBrayFEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• FitzmauriceCAllenCBarberRMGlobal, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015JAMA Oncol20173452454827918777
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer AssociationJapanese gastric cancer treatment guidelines 2014 (ver. 4)Gastric Cancer2017201119
   Web of Science ®Google Scholar
• D’AngelicaMGonenMBrennanMFTurnbullADBainsMKarpehMSPatterns of initial recurrence in completely resected gastric adenocarcinomaAnn Surg2004240580881615492562
   PubMed Web of Science ®Google Scholar
• YooCHNohSHShinDWChoiSHMinJSRecurrence following curative resection for gastric carcinomaBr J Surg200087223624210671934
   PubMed Web of Science ®Google Scholar
• WimanKGZhivotovskyBUnderstanding cell cycle and cell death regulation provides novel weapons against human diseasesJ Intern Med2017281548349528374555
   PubMed Web of Science ®Google Scholar
• StamatakosMPallaVKaraiskosICell cyclins: triggering elements of cancer or not?World J Surg Oncol2010811121176227
   PubMed Web of Science ®Google Scholar
• von Bergwelt-BaildonMSKondoEKlein-GonzálezNWendtnerCMThe cyclins: a family of widely expressed tumor antigens?Expert Rev Vaccines201110338939521434806
   PubMed Web of Science ®Google Scholar
• MuşatMMorrisDGKorbonitsMGrossmanABCyclins and their related proteins in pituitary tumourigenesisMol Cell Endocrinol20103261–2252920347931
   PubMed Web of Science ®Google Scholar
• KoEKimYChoEYSynergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancerAnn Surg Oncol20132031005101223115005
   PubMed Web of Science ®Google Scholar
• CooperWAKohonen-CorishMRMccaughanBKennedyCSutherlandRLLeeCSExpression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancerHistopathology2009551283619614764
   PubMed Web of Science ®Google Scholar
• TakashimaSSaitoHTakahashiNStrong expression of cyclin B2 mRNA correlates with a poor prognosis in patients with non-small cell lung cancerTumour Biol20143554257426524375198
   PubMedGoogle Scholar
• QianXSongXHeYCCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patientsBiomed Pharmacother20157422222726349989
   PubMed Web of Science ®Google Scholar
• LeeEJinDLeeBBNegative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitroBMC Cancer20151598226681199
   PubMed Web of Science ®Google Scholar
• XuPZhaoMLiuZElevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patientsInt J Clin Exp Pathol2015812158871589426884860
   PubMed Web of Science ®Google Scholar
• GaoTHanYYuLAoSLiZJiJCCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistancePLoS One201493e9177124622579
   PubMed Web of Science ®Google Scholar
• AgarwalRGonzalez-AnguloAMMyhreSIntegrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerClin Cancer Res200915113654366219470724
   PubMed Web of Science ®Google Scholar
• KoliadiANilssonCHolmqvistMCyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancerActa Oncol201049681682020307242
   PubMed Web of Science ®Google Scholar
• AaltonenKAminiRMHeikkiläPHigh cyclin B1 expression is associated with poor survival in breast cancerBr J Cancer200910071055106019293801
   PubMed Web of Science ®Google Scholar
• DingKLiWZouZZouXWangCCCNB1 is a prognostic biomarker for ER+ breast cancerMed Hypotheses201483335936425044212
   PubMed Web of Science ®Google Scholar
• Niméus-MalmströmEKoliadiAAhlinCCyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohortInt J Cancer2010127496196719957331
   PubMed Web of Science ®Google Scholar
• ShubbarEKovácsAHajizadehSElevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcomeBMC Cancer201313123282137
   PubMed Web of Science ®Google Scholar
• AlexanderAKarakasCChenXCyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancerOncotarget201789148971491128107181
   PubMedGoogle Scholar
• LundgrenCAhlinCHolmbergLAminiRMFjällskogMLBlomqvistCCyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control studyActa Oncol201554453854425327158
   PubMed Web of Science ®Google Scholar
• LuhtalaSStaffSTannerMIsolaJCyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancerTumour Biol20163779813982326810187
   PubMedGoogle Scholar
• CaldonCESergioCMKangJCyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cellsMol Cancer Ther20121171488149922564725
   PubMed Web of Science ®Google Scholar
• HashimotoTYanaiharaNOkamotoACyclin D1 predicts the prognosis of advanced serous ovarian cancerExp Ther Med20112221321922977490
   PubMed Web of Science ®Google Scholar
• WangHWangHMakkiMSOverexpression of β-catenin and cyclin D1 predicts a poor prognosis in ovarian serous carcinomasInt J Clin Exp Pathol20147126427124427347
   PubMed Web of Science ®Google Scholar
• AyhanAKuhnEWuRCCCNE1 copy-number gain and over-expression identify ovarian clear cell carcinoma with a poor prognosisMod Pathol201730229730327767100
   PubMed Web of Science ®Google Scholar
• PilsDBachmayr-HeydaAAuerKCyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – a study of the OVCAD consortiumEur J Cancer20145019911024176298
   PubMed Web of Science ®Google Scholar
• NakayamaNNakayamaKShamimaYGene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancerCancer2010116112621263420336784
   PubMed Web of Science ®Google Scholar
• KanskaJZakhourMTaylor-HardingBKarlanBYWiedemeyerWRCyclin E as a potential therapeutic target in high grade serous ovarian cancerGynecol Oncol2016143115215827461360
   PubMed Web of Science ®Google Scholar
• BegnamiMDFregnaniJHNonogakiSSoaresFAEvaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implicationHum Pathol20104181120112720334896
   PubMed Web of Science ®Google Scholar
• ShiHHanJYueSZhangTZhuWZhangDPrognostic significance of combined microRNA-206 and Cyclin D2 in gastric cancer patients after curative surgery: a retrospective cohort studyBiomed Pharmacother20157121021525960238
   PubMed Web of Science ®Google Scholar
• KouraklisGKatsoulisIETheocharisSDoes the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?Dig Dis Sci20095451015102019058005
   PubMed Web of Science ®Google Scholar
• RhodesDRKalyana-SundaramSMahavisnoVOncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profilesNeoplasia20079216618017356713
   PubMed Web of Science ®Google Scholar
• SzászAMLánczkyANagyÁCross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patientsOncotarget2016731493224933327384994
   PubMedGoogle Scholar
• KuleshovMVJonesMRRouillardADEnrichr: a comprehensive gene set enrichment analysis web server 2016 updateNucleic Acids Res201644W1W90W9727141961
   PubMed Web of Science ®Google Scholar
• CuiJChenYChouWCAn integrated transcriptomic and computational analysis for biomarker identification in gastric cancerNucleic Acids Res20113941197120720965966
   PubMed Web of Science ®Google Scholar
• WangQWenYGLiDPUpregulated INHBA expression is associated with poor survival in gastric cancerMed Oncol2012291778321132402
   PubMed Web of Science ®Google Scholar
• D’ErricoMde RinaldisEBlasiMFGenome-wide expression profile of sporadic gastric cancers with microsatellite instabilityEur J Cancer2009453461469
   PubMed Web of Science ®Google Scholar
• ChoJYLimJYCheongJHGene expression signature-based prognostic risk score in gastric cancerClin Cancer Res20111771850185721447720
   PubMed Web of Science ®Google Scholar
• RudyJValafarFEmpirical comparison of cross-platform normalization methods for gene expression dataBMC Bioinformatics20111246722151536
   PubMed Web of Science ®Google Scholar
• RungJBrazmaAReuse of public genome-wide gene expression dataNat Rev Genet2013142899923269463
   PubMed Web of Science ®Google Scholar
• SlonimDKYanaiIGetting started in gene expression microarray analysisPLoS Comput Biol2009510e100054319876380
   PubMed Web of Science ®Google Scholar
• PepeMSFengZImproving biomarker identification with better designs and reportingClin Chem20115781093109521666069
   PubMed Web of Science ®Google Scholar
• OhashiRGaoCMiyazakiMEnhanced expression of cyclin E and cyclin A in human hepatocellular carcinomasAnticancer Res2001211B65766211299822
   PubMed Web of Science ®Google Scholar
• RenshawAALoughlinKRDuttaACyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasmsMod Pathol199811109639669796723
   PubMed Web of Science ®Google Scholar
• HandaKYamakawaMTakedaHKimuraSTakahashiTExpression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosisInt J Cancer199984322523310371338
   PubMed Web of Science ®Google Scholar
• WangDGChenGWenXYWangDChengZHSunSQIdentification of biomarkers for diagnosis of gastric cancer by bioinformaticsAsian Pac J Cancer Prev20151641361136525743799
   PubMedGoogle Scholar
• KimDHPrognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancerYonsei Med J200748469470017722244
   PubMed Web of Science ®Google Scholar
• YasudaMTakesueFInutsukaSHondaMNozoeTKorenagaDOverexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological studyJ Cancer Res Clin Oncol2002128841241612200597
   PubMed Web of Science ®Google Scholar
• ShiQWangWJiaZChenPMaKZhouCISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growthOncotarget2016724364893650027183908
   PubMedGoogle Scholar
• GaoSYLiJQuXYZhuNJiYBDownregulation of Cdk1 and cyclinB1 expression contributes to oridonin-induced cell cycle arrest at G2/M phase and growth inhibition in SGC-7901 gastric cancer cellsAsian Pac J Cancer Prev201415156437644125124639
   PubMedGoogle Scholar
• YuJLeungWKEbertMPAbsence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancerBr J Cancer200388101560156512771922
   PubMed Web of Science ®Google Scholar
• TruongPKLaoTDDoanTPLeTALoss of expression of cyclin d2 by aberrant DNA methylation: a potential biomarker in vietnamese breast cancer patientsAsian Pac J Cancer Prev20151662209221325824739
   PubMedGoogle Scholar
• EvronEUmbrichtCBKorzDLoss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylationCancer Res20016162782278711289162
   PubMed Web of Science ®Google Scholar
• SalskovAHawesSESternJEHypermethylation of CCND2 may reflect a smoking-induced precancerous change in the lungJ Oncol2011201195014095014921577262
   PubMedGoogle Scholar
• HenriqueRCostaVLCerveiraNHypermethylation of cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancerJ Mol Med2006841191191817016690
   PubMed Web of Science ®Google Scholar
• TsutsuiMIizukaNMoribeTMethylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinomaClin Chim Acta20104117–851652020064498
   PubMed Web of Science ®Google Scholar
• YuJMiehlkeSEbertMPExpression of cyclin genes in human gastric cancer and in first degree relativesChin Med J2002115571071512133540
   PubMed Web of Science ®Google Scholar
• TakanoYKatoYvan DiestPJMasudaMMitomiHOkayasuICyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer casesAm J Pathol2000156258559410666388
   PubMed Web of Science ®Google Scholar
• TakanoYKatoYMasudaMOhshimaYOkayasuICyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosisJ Pathol1999189219420010547574
   PubMed Web of Science ®Google Scholar
• KeyomarsiKHerliczekTWThe role of cyclin E in cell proliferation, development and cancerProg Cell Cycle Res199731711919552414
   PubMedGoogle Scholar
• ZhangYPengZZhaoYChenLmicroRNA-25 inhibits cell apoptosis of human gastric adenocarcinoma cell line AGS via regulating CCNE1 and MYCMed Sci Monit2016221415142027120728
   PubMed Web of Science ®Google Scholar
• GravalosCJimenoAHER2 in gastric cancer: a new prognostic factor and a novel therapeutic targetAnn Oncol20081991523152918441328
   PubMed Web of Science ®Google Scholar
• SchoppmannSFJeschBZacherlJHER-2 status in primary oesophageal cancer, lymph nodes and distant metastasesBr J Surg201198101408141321618213
   PubMed Web of Science ®Google Scholar
• BangYJvan CutsemEFeyereislovaATrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialLancet2010376974268769720728210
   PubMed Web of Science ®Google Scholar
• JácomeAASankarankuttyAKdos SantosJSAdjuvant therapy for gastric cancer: what have we learned since INT0116?World J Gastroenterol201521133850385925852269
   PubMed Web of Science ®Google Scholar
• LeeMHChoYKimDHMenadione induces G2/M arrest in gastric cancer cells by down-regulation of CDC25C and proteasome mediated degradation of CDK1 and cyclin B1Am J Transl Res201581252465255
   Web of Science ®Google Scholar
• YuanCXZhouZWYangYXInhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cellsDrug Des Devel Ther20159487508
   PubMed Web of Science ®Google Scholar
• YuanCXZhouZWYangYXDanusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cellsDrug Des Devel Ther2015912931318
   PubMed Web of Science ®Google Scholar
• LiXXieHChenYLangMChenYShiLSilkworm pupa protein hydrolysate induces mitochondria-dependent apoptosis and S phase cell cycle arrest in human gastric cancer SGC-7901 cellsInt J Mol Sci20181941013
   Web of Science ®Google Scholar
• ZengJWangLLiQFoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1J Pathol2009218441942719235838
   PubMed Web of Science ®Google Scholar
• XiangHLLiuFQuanMFCaoJGLvY7-Difluoromethoxyl-5,4′-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1World J Gastroenterol201218334618462622969238
   PubMed Web of Science ®Google Scholar